2024 JP Morgan Healthcare Conference
BRUKER'S TRANSFORMATION INTO A FAST GROWTH COMPANY
Major R&D Investments Advancing Purposeful Innovation
Industry-leading Strategic R&D Investments:
▪ Drives product innovation, #1 or #2 positions, growth, margins and EPS
Fast growth in proteomics, spatial biology, IVD, biopharma, semicon for Al
Strategy to drive Leadership in the Post-Genomic Era
I
timsTOF® 4D-Proteomics Beacon® Single-Cell Biology
IsoSpark Single-Cell Omics
Canopy Spatial Proteomics
Acuity 3D Spatial Genomics
Cancer & Neuroscience
Research Tools
4D-Epiproteomics
4D-Lipidomics
4D-Metabolomics
4D-Glycobiology
2023 Bruker
MALDI Biotyper
MBT Sepsityper IVD
Molecular Diagnostics:
LiquidArray PCR Panels
GHz NMR Functional
Structural Biology
Translational Phenomics
by NMR and MS
R&D AS % OF REVENUE
10%
10%
9%
High-performance Instruments, Solution Leadership, Deep Biology and Disease Expertise
2021
Automation
NMR & MS:
Unique for Biologics
Biopharma PAT
Biopharma Software &
BRUKER
HI
HI
2023-E 2026-E
Leading Nano Tools:
Semicon Tools for Al
CleanTech Tools
Superconductors for
MRI, Fusion, Wind
Innovation with Integrity | January 8, 2024
15View entire presentation